BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21220058)

  • 1. Modulatory effects of tumor-derived heat shock protein in DNA vaccination against nasopharyngeal carcinoma.
    Wang JJ; Luo C; Li YH; Li GC
    Int Immunopharmacol; 2011 Apr; 11(4):462-7. PubMed ID: 21220058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and efficacy of a DNA vaccine encoding a human anti-idiotype single chain antibody against nasopharyngeal carcinoma.
    Luo C; Wang JJ; Li YH; Hu JY; Li GC
    Vaccine; 2010 Mar; 28(15):2769-74. PubMed ID: 20117260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma.
    Wang JJ; Liu YH; Li GC
    Int Immunopharmacol; 2015 Oct; 28(2):1026-33. PubMed ID: 26303768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of human bispecific anti-idiotype antibody to elicit humoral and cellular immune responses in mice.
    Wang JJ; Li YH; Liu YH; Song J; Guo FJ; Li YL; Li GC
    Int Immunopharmacol; 2010 Jun; 10(6):707-12. PubMed ID: 20382274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction of eukaryotic expression vector encoding human nasopharyngeal carcinoma anti-idiotype antibody single chain fragment gene G22 and its expression].
    Luo C; He XJ; Zhao Y; Zhang ZJ; Li GC
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):16-20. PubMed ID: 18245898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of human nasopharyngeal carcinoma bivalent anti-idiotype antibody vaccine and identification of its activity].
    Wang JJ; Guo FJ; Li YH; Li GC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):667-70. PubMed ID: 20619091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro anti-tumor immune mechanism of nasopharyngeal carcinoma bispecific anti-idiotype antibody.
    Wang J; Li Y; Li Y; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):777-83. PubMed ID: 20818068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant activity of GP96 C-terminal domain towards Her2/neu DNA vaccine is fusion direction-dependent.
    Pakravan N; Hashemi SM; Hassan ZM
    Cell Stress Chaperones; 2011 Jan; 16(1):41-8. PubMed ID: 20730610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
    Zhong KL; Zhang WJ; Yuan Y; Wu Y; Zhang MW; Mao N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):609-15. PubMed ID: 14706145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
    Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
    Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
    Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
    Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F
    Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
    Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
    Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A; Zahedifard F; Taghikhani M; Rafati S
    Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70.
    Wang XP; Liu GZ; Song AL; Li HY; Liu Y
    World J Gastroenterol; 2004 Nov; 10(21):3197-200. PubMed ID: 15457574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
    Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
    Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination.
    Ni J; Schirrmacher V; Fournier P
    Vaccine; 2010 Oct; 28(42):6891-900. PubMed ID: 20709006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.